TrialDrug design, development and therapy2019

Bioequivalence of paclitaxel protein-bound particles in patients with breast cancer: determining total and unbound paclitaxel in plasma by rapid equilibrium dialysis and liquid chromatography-tandem mass spectrometry.

Junling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.